Novo Nordisk and AWS Team Up to Speed Up Drug Discovery with AI

Danish pharma giant Novo Nordisk has announced a strategic partnership with Amazon Web Services (AWS), making AWS its preferred cloud provider and AI partner. The two companies will set up an AI innovation center at Novo Nordisk's London facility, using AWS AI technology and Novo Nordisk's data to speed up drug discovery, aiming to cut the time from drug target to first human dose. The collaboration is designed to modernize Novo Nordisk's tech infrastructure for next-generation drug development.